Reaction
Meningitis Listeria reporting signals
As of the last recalculation, Meningitis Listeria appears in 505 FAERS reports alongside 11 co-occurring drug terms. The strongest observed disproportionality signal is ALEMTUZUMAB (PRR 87.5).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Alemtuzumab | 38 | 87.5 | 87.7 |
| Ampicillin | 12 | 61.1 | 61.2 |
| Ampicillin Sodium | 12 | 61.1 | 61.2 |
| Daratumumab | 43 | 48.4 | 48.4 |
| Infliximab | 130 | 32.7 | 32.7 |
| Atovaquone | 5 | 25.8 | 25.9 |
| Anakinra | 10 | 25.3 | 25.3 |
| Bortezomib | 39 | 19.4 | 19.4 |
| Canakinumab | 5 | 19.2 | 19.2 |
| Carfilzomib | 12 | 17.9 | 17.9 |
| Obinutuzumab | 6 | 15.2 | 15.2 |